Clinical Trials
45 trialsUsing Aspirin to Improve Immunological Features of Ovarian Tumors
H. Lee Moffitt Cancer Center and Research Institute
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy
Ohio State University Comprehensive Cancer Center
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer
Cedars-Sinai Medical Center
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
Memorial Sloan Kettering Cancer Center
Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Mayo Clinic
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
University of South Florida
TOASTIT
Mayo Clinic
Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors
Peking University
FPA150-001
Five Prime Therapeutics, Inc.
IMPACT
Haukeland University Hospital
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
CCT-ANK-11
Beijing Kejing Biotechnology Co., Ltd.
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer
Mainline Biosciences, Inc.
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
OHSU Knight Cancer Institute
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Shanghai Yunying Medical Technology
PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer
University of Texas Southwestern Medical Center
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy
National Cancer Institute (NCI)
Vitamin D, Leptin, Vitamin D Receptor Polymorphism, and Treatment-Related Morbidity in Ovarian Cancer
University of Oklahoma
MOLTO
The Christie NHS Foundation Trust
YSCH-01
Shanghai Fengxian District Central Hospital
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer
Roswell Park Cancer Institute
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer
Shanghai 6th People's Hospital
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors
Shanghai Cell Therapy Group Co.,Ltd
Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
Vastra Gotaland Region
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
New Mexico Cancer Research Alliance
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Masonic Cancer Center, University of Minnesota
Amatuximab for High Mesothelin Cancers
National Institutes of Health Clinical Center (CC)
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Zhejiang University
Fermented Wheat Germ Extract in Women With Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute
Combination Chemotherapy in Treating Patients With Sarcoma
Mayo Clinic
Autologous OC-DC Vaccine in Ovarian Cancer
Abramson Cancer Center at Penn Medicine
PET Imaging of Ovarian Carcinoma With 18F-FSPG
Vanderbilt-Ingram Cancer Center
OCEDP
Swedish Medical Center
Interactive Educational Website for Women With Ovarian Cancer & Caregivers
University of Minnesota
PET-CT vs. Integrated MR-PET Scanning of GYN Cancers
Massachusetts General Hospital
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
National Institutes of Health Clinical Center (CC)
11C Topotecan PET Imaging
Case Comprehensive Cancer Center
Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.
Memorial Sloan Kettering Cancer Center